Patents associated with high-cost drugs in Australia.
Andrew F Christie; Chris Dent; Peter McIntyre; Lachlan Wilson; David M Studdert;
- Publisher: Public Library of Science (PLoS)
- Journal: PLoS ONE,volume 8,issue 4 (issn: 1932-6203, eissn: 1932-6203)
Related identifiers: ,
- Subject: Social and Behavioral Sciences | Research Article | Drug Licensing and Regulation | Law | Medicine | Health Care Policy | Drug Research and Development | Drug Policy | Q | R | Drugs and Devices | Drug Discovery | Science | Commercial Law | Public Health | Non-Clinical Medicine | Health Economicsmesheuropmc: health care economics and organizations
Australia, like most countries, faces high and rapidly-rising drug costs. There are longstanding concerns about pharmaceutical companies inappropriately extending their monopoly position by “evergreening” blockbuster drugs, through misuse of the patent system. There is,... View more